SATRALIZUMAB

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Approval Year

Substance Class	Protein Created by `admin` on `Wed Apr 02 06:59:08 GMT 2025` Edited by `admin` on `Wed Apr 02 06:59:08 GMT 2025`
Protein Type	MONOCLONAL ANTIBODY
Protein Sub Type	IGG2
Sequence Origin	HUMANIZED MOUSE
Sequence Type	COMPLETE
Record UNII	YB18NF020M
Record Status	`Validated (UNII)`
Record Version

Download

Related Record	Type

Name

Type

Language

SAPELIZUMAB

Preferred Name

English

SATRALIZUMAB

Official Name

English

SA237

Code

English

SATRALIZUMAB [USAN]

Common Name

English

SATRALIZUMAB [MI]

Common Name

English

HUMANISED ANTI-IL-6 RECEPTOR MONOCLONAL ANTIBODY

Common Name

English

SA-237

Code

English

IMMUNOGLOBULIN G2-KAPPA, ANTI-(HUMAN INTERLEUKIN-6 RECEPTOR SUBUNIT ALPHA (IL-6RA, MEMBRANE GLYCOPROTEIN 80, CD126 ANTIGEN)) HUMANIZED MONOCLONAL ANTIBODY: .GAMMA.2 HEAVY CHAIN (1-443) (HUMANIZED VH (HOMO SAPIENS IGHV4-59*01 (76%) (IGHD)-IGHJ4*01 (92%))

Systematic Name

English

SATRALIZUMAB [JAN]

Common Name

English

satralizumab [INN]

Common Name

English

IMMUNOGLOBULIN G2, ANTI-(HUMAN INTERLEUKIN 6 RECEPTOR) (HUMAN-MUS MUSCULUS MONOCLONAL SA237 HEAVY CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL SA237 LIGHT CHAIN, DIMER

Common Name

English

Satralizumab [WHO-DD]

Common Name

English

Classification Tree Code System Code

NCI_THESAURUS

C20401

Created by admin on Wed Apr 02 06:59:08 GMT 2025 , Edited by admin on Wed Apr 02 06:59:08 GMT 2025

EU-Orphan Drug

EU/3/16/1680

Created by admin on Wed Apr 02 06:59:08 GMT 2025 , Edited by admin on Wed Apr 02 06:59:08 GMT 2025

NCI_THESAURUS

C574

Created by admin on Wed Apr 02 06:59:08 GMT 2025 , Edited by admin on Wed Apr 02 06:59:08 GMT 2025

Code System Code Type Description

DAILYMED

YB18NF020M

Created by admin on Wed Apr 02 06:59:08 GMT 2025 , Edited by admin on Wed Apr 02 06:59:08 GMT 2025

PRIMARY

RXCUI

2391541

Created by admin on Wed Apr 02 06:59:08 GMT 2025 , Edited by admin on Wed Apr 02 06:59:08 GMT 2025

PRIMARY

SMS_ID

100000181406

Created by admin on Wed Apr 02 06:59:08 GMT 2025 , Edited by admin on Wed Apr 02 06:59:08 GMT 2025

PRIMARY

USAN

DE-75

Created by admin on Wed Apr 02 06:59:08 GMT 2025 , Edited by admin on Wed Apr 02 06:59:08 GMT 2025

PRIMARY

FDA UNII

YB18NF020M

Created by admin on Wed Apr 02 06:59:08 GMT 2025 , Edited by admin on Wed Apr 02 06:59:08 GMT 2025

PRIMARY

INN

10065

Created by admin on Wed Apr 02 06:59:08 GMT 2025 , Edited by admin on Wed Apr 02 06:59:08 GMT 2025

PRIMARY

NCI_THESAURUS

C152307

Created by admin on Wed Apr 02 06:59:08 GMT 2025 , Edited by admin on Wed Apr 02 06:59:08 GMT 2025

PRIMARY

CAS

1535963-91-7

Created by admin on Wed Apr 02 06:59:08 GMT 2025 , Edited by admin on Wed Apr 02 06:59:08 GMT 2025

PRIMARY

MERCK INDEX

m12223

Created by admin on Wed Apr 02 06:59:08 GMT 2025 , Edited by admin on Wed Apr 02 06:59:08 GMT 2025

PRIMARY

WIKIPEDIA

Satralizumab

Created by admin on Wed Apr 02 06:59:08 GMT 2025 , Edited by admin on Wed Apr 02 06:59:08 GMT 2025

PRIMARY

From	To
1_22	1_96
1_146	1_202
1_259	1_319
1_365	1_423
2_22	2_96
2_146	2_202
2_259	2_319
2_365	2_423
1_222	3_214
2_222	4_214
1_225	2_225
1_228	2_228
3_23	3_88
3_134	3_194
4_23	4_88
4_134	4_194

Glycosylation Type

HUMAN

Glycosylation Link Type	Site
N	1_295
N	2_295

Related Record Type Details


					156G191JXJ

INTERLEUKIN 6 RECEPTOR

TARGET -> INHIBITOR

SATRALIZUMAB-MWGE

SUB_CONCEPT->SUBSTANCE

Amount:

Related Record Type Details


					YB18NF020M

ACTIVE MOIETY

Name	Property Type	Amount	Referenced Substance	Defining	Parameters	References
MOL_WEIGHT:SEQUENCE(CALCULATED)	CHEMICAL
Molecular Formula	CHEMICAL